Anera Life Inc., a Canadian longevity health company dedicated to developing scientifically grounded NAD+ and mitochondrial optimization products, is proud to announce the appointment of Dr. Paul Sidhu, M.D., CCFP to its Scientific Advisory Board.
Dr. Sidhu, a highly respected physician with more than a decade of clinical experience in family medicine, preventive care, and emerging longevity sciences, brings significant expertise to Anera’s rapidly growing scientific ecosystem. His background spans patient-focused primary care, evidence-based wellness strategies, peptide research, biomarker interpretation, and nanometallic biomedical innovation.
A Longstanding Professional Partnership with Anera’s Chief Science Officer & President
Dr. Sidhu has collaborated for years with Dr. Andrew J.M. Willoughby, DMD, LVIF, FAGD, FICOI, FAACFP, MICCMO, Anera Life’s Chief Science Officer and President.
Together, they have contributed to:
- Advanced peptide and mitochondrial research
- Nanometallic biomedical system development
- Longevity-focused diagnostic frameworks
- Regenerative and epigenetic optimization models
Their long-standing partnership forms a cornerstone of Anera Life’s scientific direction and strategic vision.
Driving Anera Life’s Scientific Mission Forward
In his role on the Scientific Advisory Board, Dr. Sidhu will:
- Provide guidance on Anera’s ongoing longevity research initiatives
- Support scientific oversight for product development and future formulations
- Contribute to educational and clinical advisory materials
- Assist in reviewing emerging science related to NAD+, mitochondrial function, peptides, and preventative aging models
His clinical judgment, scientific acumen, and multidisciplinary experience align seamlessly with Anera’s mission to develop trusted, research-backed solutions that support human resilience, energy optimization, and long-term vitality.
Executive Statements
“Dr. Sidhu’s clinical insight and scientific discipline add immense value to Anera’s mission,” said Dr. Andrew Willoughby, Chief Science Officer and President of Anera Life.
“Our long-standing collaboration has shown me his rare ability to bridge traditional medicine with advanced longevity science. His addition strengthens our foundation as we expand our research and product development efforts.”
“I am honoured to join Anera’s Scientific Advisory Board,” said Dr. Sidhu.
“Anera Life is shaping the future of longevity through rigorous science, ethical innovation, and a commitment to improving quality of life. I look forward to contributing to this mission in a meaningful way.”
Anera Life Founder Truc Tran added:
“Dr. Sidhu’s knowledge, integrity, and passion for patient-centered longevity align perfectly with our vision. His presence on the board will help deepen Anera’s scientific credibility and accelerate our research-driven roadmap.”
About Anera Life Inc.
Anera Life Inc. is a Canadian longevity health company focused on NAD+ optimization, mitochondrial support, and evidence-based anti-aging solutions. Founded on a mission of moving from Pain to Purpose, Anera develops premium-grade supplements and research-driven health systems designed to help individuals experience greater energy, clarity, and long-term vitality. Led by Chief Science Officer and President Dr. Andrew Willoughby, Anera continues to expand its scientific foundation and global reach.
Learn more at: www.aneralife.com
